AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | +33.8% | 20,047 | +19.6% | 0.02% | +25.0% |
| Q1 2023 | $154 | +40.0% | 16,759 | +9.5% | 0.02% | +6.7% |
| Q4 2022 | $110 | -99.8% | 15,310 | +45.2% | 0.02% | +200.0% |
| Q3 2022 | $53,000 | -74.1% | 10,541 | -58.5% | 0.01% | -76.2% |
| Q4 2021 | $205,000 | +111.3% | 25,427 | +75.8% | 0.02% | +110.0% |
| Q4 2020 | $97,000 | -63.7% | 14,461 | -56.2% | 0.01% | -67.7% |
| Q2 2020 | $267,000 | +151.9% | 33,048 | +155.0% | 0.03% | +416.7% |
| Q4 2017 | $106,000 | -23.7% | 12,959 | -1.9% | 0.01% | -14.3% |
| Q3 2017 | $139,000 | – | 13,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
| Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
| JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
| FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
| Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
| KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
| HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
| Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |